Krds peptide is a synthetic tetrapeptide derived from lactotransferrin (residues 39 to 42); inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-Stimulated platelets and megakaryocytes. References: Lévy-Toledano S, Grelac F, Caen JP, Maclouf J. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism. Thromb Haemost. 1995 May;73(5):857-61. PubMed PMID: 7482416.

纯度：≥98%

CAS：116430-80-9